insights_auto
Outlook: 55.6% bullish·11.1% bearish
Go to analysischevron_right
RXRX:NASDAQ
Recursion Pharmaceuticals Inc
$3.66
arrow_upward
+1.39%(+0.050) 1D
$3.65
arrow_downward
-0.27% (-0.0100)bedtimeAfter hours
Closed: Oct 20, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RXRX...
Open
$3.56
High
$3.67
Low
$3.47
Mkt. cap
2.18B
Avg. vol.
28.04M
Volume
20.91M
52-wk high
$6.70
52-wk low
$2.77
EPS
-$1.04
Beta
1.04
Shares outstanding
596.88M
No. of employees
600
Open
$3.56
High
$3.67
Low
$3.47
Mkt. cap
2.18B
Avg. vol.
28.04M
Volume
20.91M
52-wk high
$6.70
52-wk low
$2.77
EPS
-$1.04
Beta
1.04
Shares outstanding
596.88M
No. of employees
600
News stories
From web sources and news partners
Zacks
·
2 hours ago
Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing
Simply Wall Street
·
2 hours ago
Sanofi Drug Option Might Change The Case For Investing In Recursion Stock (RXRX)
Timothy Sykes
·
1 day ago
RXRX Stock Pops As Sanofi Deal And ARK Buying Fuel AI-Drug Hype
Timothy Sykes
·
1 day ago
RXRX Stock Pops As Sanofi Deal, ARK Buying Fuel AI Biotech Story
About Recursion Pharmaceuticals Inc
CEONajat Khan
Employees600
Founded2013
HeadquartersSalt Lake City, Utah, United States
SectorBiotechnology
Websiterecursion.com